WASHINGTON — Joe Biden recently underwent skin cancer surgery, a spokesperson confirmed to USA TODAY, just months after the former president was diagnosed with prostate cancer. According to the ...

(WGHP) — Piedmont Attorney David Daggett has competed in over 200 triathlons, including 34 Ironman events, which is considered the ultimate test, a 2.4-mile swim followed by a 112-mile bike, ending ...

After revealing that she'd been diagnosed with ovarian cancer in 2021, Christiane Amanpour is managing the disease for a third time. The CNN news anchor revealed her latest diagnosis during an ...

Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this year. Chugai revealed (PDF) the suspension of in-house development of the ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin cancer who were ...

The messenger RNA (mRNA) COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are improving how long people with cancer survive ...

Christiane Amanpour's cancer journey has been a winding one, but she's pulling through. The 67-year-old British Iranian journalist and CNN chief international anchor revealed that she's battling ...

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new study found that mRNA vaccines were linked to a doubling in three-year ...

The Boston Bruins will host Hockey Fights Cancer Night, presented by Mass General Brigham, on Thursday, October 23, during their home game against the Anaheim Ducks at 7 p.m. at TD Garden. Lavender, ...

Routine mammograms are the mainstay of breast cancer screening. But, with a new type of analysis powered by artificial intelligence, doctors may be able to also predict whether or not you'll develop ...

Takeda is paying Innovent Biologics $1.2 billion upfront for rights to two cancer candidates. The deal, which includes (PDF) $10.2 billion in milestones, puts the biologics at the center of Takeda’s ...